MedCost Clearmedcostclear.com · data checked Nov 15, 2026
Medicare GLP-1 Bridge: who qualifies, what it costs, key dates
For people with Medicare drug coverage (Part D). GLP-1 drugs for weight management.
May be out of date — see https://medcostclear.com/insurance/medicare/
- A known change date has passed since this sheet was built.
What it is
- A temporary Medicare program that covers certain GLP-1 drugs for weight management. It runs outside Medicare Part D plans, with its own central processor for prior authorization and payment.[1]
Which drugs
- Foundayo (tablet), Wegovy (injection or tablet) and Zepbound KwikPen only. Single-dose Zepbound vials and pens are not covered.[2]
What it costs
- A $50 copayment to the pharmacy for a one-month supply (28 or 30 days, depending on the drug).[2]
- The copayment does not count toward the Part D plan's yearly deductible or out-of-pocket limit, does not appear on the Part D Explanation of Benefits (EOB), and cannot be lowered by Extra Help.[2]
Who qualifies
- Age 18 or older, and one of these when GLP-1 therapy starts:[2]
- Body mass index (BMI) of 35 or higher; or
- BMI of 30 or higher with diastolic heart failure (heart failure with preserved ejection fraction), uncontrolled high blood pressure, or chronic kidney disease stage 3a or higher; or
- BMI of 27 or higher with prediabetes, a previous heart attack or stroke, or peripheral artery disease with symptoms.
- Not eligible: people who already get GLP-1 drugs covered through their Part D plan, or who have type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease (their Part D plan might cover their GLP-1s).[2]
How to start
- The doctor or other prescriber sends a prescription for a covered GLP-1 drug to the pharmacy and, when asked, completes a prior authorization.[2]
- The prescriber must certify that the drug is used as part of a lifestyle program focused on diet and exercise.[2]
Key dates
- Coverage started July 1, 2026.[2]
- CMS extended the program through December 31, 2027.[3]
- An approved prior authorization is valid, including refills and dose changes, through December 31, 2027, unless the person changes GLP-1 drugs.[2]
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[4]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[4]
Official sources (date our archive last confirmed each one)
- CMS: Medicare GLP-1 Bridge information for prescribers. https://www.cms.gov/files/document/glp-1-prescribers-c-1.pdf — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/insurance/medicare/ · Sheet built Nov 15, 2026. How we keep it current: archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.